Grail (GRAL) Net Income towards Common Stockholders Growth (3y) (2026)
Powered by 
Analysis
Grail (GRAL) Net Income towards Common Stockholders Growth (3y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 15.47% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.22% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 16.51% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -18.19% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 28.59% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 31.64% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 30.27% |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 17.03% |